Copyright
©The Author(s) 2019.
World J Diabetes. May 15, 2019; 10(5): 269-279
Published online May 15, 2019. doi: 10.4239/wjd.v10.i5.269
Published online May 15, 2019. doi: 10.4239/wjd.v10.i5.269
Clinical parameter | Diabetic nephropathy | Non-proteinuric diabetic nephropathy |
Proteinuria | Present | Absent |
Regression of proteinuria | Present | Absent |
Histology | Abnormal | Normal or abnormal |
Glomerular filtration rate | Decreased | Decreased |
Increased risk of chronic kidney disease | Present | Present |
Field | Summary of non-proteinuric diabetic nephropathy literature |
Prevalence | 57% of diabetic nephropathy patients |
Pathogenesis | Vascular and soluble elements, such as uric acid, TNFα, and VEGF, affecting renal microhemodynamics |
Diagnosis | (1) Increased renal resistive index; (2) Alterations in TNFα, TGF-β, endothelin, and other interleukins |
Treatment | (1) Enalapril; (2) Losartan; (3) Heparin; (4) Pentoxifylline |
- Citation: Kopel J, Pena-Hernandez C, Nugent K. Evolving spectrum of diabetic nephropathy. World J Diabetes 2019; 10(5): 269-279
- URL: https://www.wjgnet.com/1948-9358/full/v10/i5/269.htm
- DOI: https://dx.doi.org/10.4239/wjd.v10.i5.269